ArticleAnnals of medicine and surgery (2012)2025

From surgery to immunotherapy: Papzimeos as the first FDA-approved therapy for recurrent respiratory papillomatosis (RRP).

Haris Afridi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.